跳至主要内容
临床试验/NCT06831253
NCT06831253招募中不适用

Efficacy of Restoration of Lacrimal Secretion After Injection of Platelet-Rich Plasma (PRP) Into the Lacrimal Gland in Severe Dry Eye Syndromes (ReLIPSSO)

Centre Hospitalier Universitaire de Nice1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年3月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
To compare the lacrimal secretion after 4 monthly injections of PRP into the lacrimal gland

研究概览

简要总结

The investigatror wants to show the efficacy of Platelet-Rich Plasma injection in lacrimal gland to restore the lacrimal secretion in patients presenting aqueous deficiency reponsible for severe dry eye syndrome.

详细描述

injections in lacrimal gland four times during the study for each patient

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

To assess the lacrimal secretion after 4 injections of PRP in lacrimal gland

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Platelet counts, and clotting factors in the standarts
  • •Presenting with severe dry keratoconjunctivitis diagnosed by an ophthalmologist

排除标准

  • •Patients with significant fibrosis of the conjunctival portion of the lacrimal gland
  • •Patients with complete stenosis of both lacrimal meatus in the treated eye

研究组 & 干预措施

Injection of Platelet-Rich Plasma (PRP)

Experimental

干预措施: injections of Platelet-Rich Plasma in lacrimal gland (Other)

结局指标

主要结局

To compare the lacrimal secretion after 4 monthly injections of PRP into the lacrimal gland

时间窗: week 16

Schirmer I test score between 0mm and more 20mm

次要结局

  • To compare the different clinical follow-up parameters of qualitative dry ocular syndrome and quantitative after 4 monthly injections of PRP into the lacrimal gland(week 16)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验